Dovetail Genomics

Dovetail Genomics is reimagining the life sciences by unlocking access to genomic structure at an unparalleled level. Through Dovetail Genomics proprietary proximity ligation technologies, the 3-D architecture of the genome is captured alongside primary sequence information using standard next-generation sequencing (NGS) approaches. Researchers are using Dovetail Genomics unique methods to solve complex problems including chromatin topology analysis, small and large structural variant detection, de novo chromosome assembly, haplotype phasing and microbiome analysis in the fields of epigenetics, developmental biology, cancer research, evolutionary biology and more. Through our services and assay kit offerings, Dovetail Genomics is ready to partner with you...

Genome assembly,genomics,de novo assembly ,scaffolding ,proximity ligation ,gap filling ,hichip,micro-c,epigenetics,chip-seq,chromatin topology,and 3d chromosome architecture

Dovetail genomics operates in the Biotechnology research industry.

Dovetail genomics's revenue is 11m - 100m

Dovetail genomics has 11 - 50 employees.